Efficacy and time-efficiency of a "sonographer-driven" contrast echocardiography protocol in a high-volume echocardiography laboratory

被引:28
作者
Castello, R
Bella, JN
Rovner, A
Swan, J
Smith, J
Shaw, L
机构
[1] Univ Hosp Cleveland, Dept Med, Div Cardiol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Emory Univ, Atlanta, GA 30322 USA
关键词
D O I
10.1067/mhj.2003.164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Contrast echocardiography (CE) has not gained widespread use despite numerous studies, demonstrating its efficacy in the assessment of left ventricular (LV) function. Methods We sought to determine whether CE could be used in a high-volume echocardiography laboratory in a clinically effective and time efficient manner. We implemented a protocol with a feasibility phase and an established phase. Cost-benefit analyses were done on the basis of time use. Results During the feasibility and established phases, data on 119 and 672 patients, respectively, were obtained. After a "sonographer-driven" protocol, contrast studies represented 7% to 8% of the total number of routine transthoracic and stress studies: Stress studies accounted for only 15% of the total number of contrast studies. Obesity was the most common indication for contrast use. LV visualization indices and wall thickening assessment, as evaluated by 2 blinded readers, were significantly improved with CE compared with second harmonic imaging alone. The time to make the decision to use CE and the time taken to administer contrast decreased significantly from the feasibility phase to the established phase (8.3 +/- 5 vs 7.6 +/- 5 min, P < .01, and 13.4 +/- 10 vs 10.2 +/- 5 min, P < .001, respectively). On the basis of,time use only, a cost analysis indicated that savings were obtained at a 10-minute reduction in study time. Conclusions A "sonographer-driven" CE protocol for LV assessment is feasible in high-volume echocardiography laboratories. It is clinically effective because it significantly improves LV global and regional wall motion visualization. A "sonographer-driven" CE protocol can reduce decision and administration times substantially, thus making CE time-efficient.
引用
收藏
页码:535 / 541
页数:7
相关论文
共 18 条
  • [1] Burns PN, 1996, CLIN RADIOL, V51, P50
  • [2] Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent - Results of a phase III multicenter trial
    Cohen, JL
    Cheirif, J
    Segar, DS
    Gillam, LD
    Gottdiener, JS
    Hausnerova, E
    Bruns, DE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) : 746 - 752
  • [3] OPACIFICATION AND BORDER DELINEATION IMPROVEMENT IN PATIENTS WITH SUBOPTIMAL ENDOCARDIAL BORDER DEFINITION IN ROUTINE ECHOCARDIOGRAPHY - RESULTS OF THE PHASE-III ALBUNEX MULTICENTER TRIAL
    CROUSE, LJ
    CHEIRIF, J
    HANLY, DE
    KISSLO, JA
    LABOVITZ, AJ
    RAICHLEN, JS
    SCHUTZ, RW
    SHAH, PM
    SMITH, MD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) : 1494 - 1500
  • [4] INTRAVENOUS ALBUNEX DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY - ENHANCED LOCALIZATION OF LEFT-VENTRICULAR ENDOCARDIAL BORDERS
    FALCONE, RA
    MARCOVITZ, PA
    PEREZ, JE
    DITTRICH, HC
    HOPKINS, WE
    ARMSTRONG, WF
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (02) : 254 - 258
  • [5] SAFETY AND EFFICACY OF A NEW TRANSPULMONARY ULTRASOUND CONTRAST AGENT - INITIAL MULTICENTER CLINICAL-RESULTS
    FEINSTEIN, SB
    CHEIRIF, J
    TENCATE, FJ
    SILVERMAN, PR
    HEIDENREICH, PA
    DICK, C
    DESIR, RM
    ARMSTRONG, WF
    QUINONES, MA
    SHAH, PM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (02) : 316 - 324
  • [6] Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms
    Grayburn, PA
    Weiss, JL
    Hack, TC
    Klodas, E
    Raichlen, JS
    Vannan, MA
    Klein, AL
    Kitzman, DW
    Chrysant, SG
    Cohen, JL
    Abrahamson, D
    Foster, E
    Perez, JE
    Aurigemma, GP
    Panza, JA
    Picard, MH
    Byrd, BF
    Segar, DS
    Jacobson, SA
    Sahn, DJ
    DeMaria, AN
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) : 230 - 236
  • [7] Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: Comparison with cine magnetic resonance imaging
    Hundley, WG
    Kizilbash, AM
    Afridi, I
    Franco, F
    Peshock, RM
    Grayburn, PA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) : 1426 - 1432
  • [8] Comparison of native and contrast-enhanced harmonic echocardiography for visualization of left ventricular endocardial border
    Kasprzak, JD
    Paelinck, B
    Ten Cate, FJ
    Vletter, WB
    de Jong, N
    Poldermans, D
    Elhendy, A
    Bouakaz, A
    Roelandt, JRTC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (02) : 211 - 217
  • [9] KAUL S, 1997, CLIN CARDIOL, V20, P127
  • [10] KITZMAN DW, 1998, J AM SOC ECHOCARDIOG, V11, P555